Science Explorer Back to mapMap
Discussion
Researcher · Hospital Central Dr. Ignacio Morones Prieto · Mexico

Carlos Abud‐Mendoza

Carlos Abud‐Mendoza publishes mostly in Rheumatology, Immunology and Epidemiology, on topics such as Systemic Lupus Erythematosus Research, Rheumatoid Arthritis Research and Therapies and Autoimmune and Inflammatory Disorders Research.

ORCID 0000-0002-3749-5831 OpenAlex
World rank
#1,443,877
of 7,710,434 ranked researchers
Rank in Mexico
#3,454
of 55,557
Works
247
Citations
8.1k
Citations per work
32.7
h-index
42
i10-index 93Top 5% in Rheumatology
Carlos Abud‐Mendoza

What does Carlos Abud‐Mendoza research?

Carlos Abud‐Mendoza's work is mostly in Medicine (46%), Immunology and Microbiology (12%).

Health Sciences: 113 works · 45.7% of their workMedicine: 113 works · 45.7% of their workRheumatology: 72 works · 29.0% of their workEpidemiology: 11 works · 4.4% of their workHematology: 11 works · 4.4% of their workPathology and Forensic Medicine: 10 works · 4.1% of their workPulmonary and Respiratory Medicine: 9 works · 3.8% of their workEverything else: 103 works · 41.9% of their workLife Sciences: 31 works · 12.4% of their workImmunology and Microbiology: 31 works · 12.4% of their workImmunology: 31 works · 12.4% of their workTHEIR WORKCarlosAbud‐Mendoza247works
Life Sciences12%Health Sciences46%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine11345.7%
  2. Everything else10341.9%
    1. Immunology and Microbiology3112.4%
  1. 1Rheumatology29% of their works
  2. 2Immunology12% of their works
  3. 3Epidemiology4% of their works
  4. 4Hematology4% of their works
  5. 5Pathology and Forensic Medicine4% of their works
  6. 6Pulmonary and Respiratory Medicine4% of their works

Research topics

Which keywords describe Carlos Abud‐Mendoza's research?

The keywords of their largest research topics: Autoantibodies, Antiphospholipid Syndrome, Systemic Lupus Erythematosus, Inflammation, Rheumatoid Arthritis, Hemophagocytic Lymphohistiocytosis, Juvenile Idiopathic Arthritis and Monoclonal Antibodies.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Autoantibodies1813 topics
  2. Antiphospholipid Syndrome991 topic
  3. Systemic Lupus Erythematosus991 topic
  4. Inflammation661 topic
  5. Rheumatoid Arthritis661 topic
  6. Hemophagocytic Lymphohistiocytosis271 topic
  7. Juvenile Idiopathic Arthritis271 topic
  8. Monoclonal Antibodies272 topics
  9. Foxp3191 topic
  10. TGF-ß191 topic
  11. Fibrosis161 topic
  12. Systemic Sclerosis161 topic
  13. NK Cell Recognition151 topic
  14. Natural Killer Cells151 topic
  15. Fc Receptors141 topic
  16. Therapeutic Antibodies141 topic
  17. Biosimilars131 topic
  18. Immunogenicity131 topic

Where does Carlos Abud‐Mendoza work?

Carlos Abud‐Mendoza's main affiliation in the publication record is Hospital Central Dr. Ignacio Morones Prieto, Mexico.

How many publications and citations does Carlos Abud‐Mendoza have?

OpenAlex counts 247 works and 8,073 citations for Carlos Abud‐Mendoza, an h-index of 42, ranking #1,443,877 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Carlos Abud‐Mendoza. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.